Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This ia a multicenter, Single-Arm, Open-Label Phase I Clinical Study Evaluating the Safety
and Tolerability of Pelareorep Combined with Paclitaxel Injection and the Intracorporal
Process of Pelareorep in Chinese Patients with Advanced or Metastatic Breast Cancer.